PlexusDx screens for this during intake, and all thyroid patients receive enhanced monitoring schedules
Thiazides diuretics usually do not affect normal blood pressure
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
No conclusions can be made for efficacy or safety outcomes beyond glycemic reduction and weight loss since these outcomes were not evaluated
Insulin resistance, common in people with excess weight, impairs glucose utilization by neurons
Neuroendocrinology Letters, 23 , 365-368